Tumor phenotype and concordance in synchronous bilateral breast cancer in young women
- 1 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 186 (3), 815-821
- https://doi.org/10.1007/s10549-020-06027-0
Abstract
Purpose Synchronous bilateral breast cancer is uncommon, and its pattern and incidence among younger women is unknown. Here we report the incidence, phenotypes, and long-term oncologic outcomes of bilateral breast cancer in women enrolled in the Young Women's Breast Cancer Study (YWS). Methods The YWS is a multi-center, prospective cohort study of women with breast cancer diagnosed at age <= 40 years. Those with synchronous bilateral breast cancer formed our study cohort. Tumor phenotypes were categorized as luminal A (hormone receptor (HR)+/HER2-/grade 1/2), luminal B (HR+ /HER2+ or HER2- and grade 3), HER2-enriched (HR-/HER2+), or basal-like (HR-/HER2-). Descriptive statistics were used to evaluate tumor phenotypes of bilateral cancers for concordance. Results Among 1302 patients enrolled in the YWS, 21 (1.6%) patients had synchronous bilateral disease. The median age of diagnosis was 38 years (range 18-40 years). Seventeen (81.0%) underwent genetic testing with 6 found to have pathogenic germline mutations in BRCA1, BRCA2, or TP53. The majority of patients (76.2%) underwent bilateral mastectomy. On pathology, 2 patients had bilateral in-situ disease, 6 had unilateral invasive and contralateral in-situ disease, and 13 had bilateral invasive disease. Of those with bilateral invasive disease, 10 (76.9%) had bilateral luminal tumors and, when fully characterized, 6 were of the same luminal subtype. Only 1 patient had bilateral basal-like breast cancer. At median follow-up of 8.2 years, 14 patients are alive with no recurrent disease. Conclusions Bilateral breast cancer is uncommon among young women diagnosed with breast cancer at age <= 40. In our cohort, the majority of invasive tumors were of the luminal phenotype, though some differed by grade or HER2 status. These findings support the need for thorough pathologic workup of bilateral disease when it is found in young women with breast cancer to determine risk and tailor treatment.This publication has 18 references indexed in Scilit:
- Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast CancerJournal of Adolescent and Young Adult Oncology, 2019
- National trends of synchronous bilateral breast cancer incidence in the United StatesBreast Cancer Research and Treatment, 2019
- BRCA1andBRCA2Mutation Testing in Young Women With Breast CancerJAMA Oncology, 2016
- Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast CancerJournal of Clinical Oncology, 2014
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Clinicopathological Features in Bilateral Breast CancerAsian Pacific Journal of Cancer Prevention, 2012
- Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristicsBreast Cancer Research and Treatment, 2010
- Incidence and Prognosis of Synchronous and Metachronous Bilateral Breast CancerJournal of Clinical Oncology, 2007
- Bilateral breast carcinomaCancer, 2000
- Simultaneous bilateral breast carcinomas: A retrospective review of 149 casesInternational Journal of Radiation Oncology*Biology*Physics, 1994